Caroline Cayre

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France.

CEA Investissement SA (CEA-I), formerly known as CEA Valorisation, is the corporate venture arm and a wholly-owned subsidiary of CEA-Commissariat à l'Energie Atomique, which is the French governmental agency in charge of civilian and defense nuclear research. CEA-I was established in 1999 and is located in Grenoble, a large city in the southeast of France. CEA-I manages a portfolio of direct participations in high-technology companies. The firm also provides services related to IP protection for research done at CEA, by other public research entities or within private companies.

France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.

BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.

CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France.

ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France.

ETHERA SA provides diagnostic kits for indoor air pollution. It also develops solutions for measurement of chemical pollutants in the indoor air, especially for toxic volatile organic compounds. The firm's products include Profil'air modules, Profil'air sensors and Profil'air accessories. The company was founded by Yves Bigay, Thu-Hoa Tran-Thi and Sylvain Colomb in 2010 and is headquartered in Crolles, France.

Algaïa SA generates products and fermentation processes for the chemical and pharmaceutical industry. It products include carrageenan’s, alginates, plant bio stimulants and specialty seaweed extracts. The firm offers biomass valorization, biochemical analyses and bioactivity measurement services. The company was founded by Rudy Pandjaitan on July 30, 2004 and is headquartered in Paris, France.

SymbioFCell SA manufactures and industrializes hydrogen fuel systems. It also engages in the development, assembly and integration of its fuel systems. The firm’s product applications include industrial and automotive embarkation, such as short- and mid-range trucks, industrial and specialized vehicles, buses, trams, ferries and barges. The company was founded by Fabio Ferrari in 2010 and is headquartered in Grenoble, France.

Multix SA manufactures spectrometric X-ray. The firm designs, produces and sells advanced spectrometric X-ray detectors, used for the identification of materials in general, non-destructive testing and the detection of explosives in luggage and packages in particular. The company was founded by Jacques Doremus and Patrick Radisson in 2010 and is headquartered in Neuilly-sur-Seine, France.

Nanomakers SA designs and manufactures silicon carbide nanopowders. It offers increase in mechanical and chemical performance for different industrial equipments and materials such as buildings, aeronautics, space, nuclear, automotive and semiconductors. The company was founded by François Tenegal in January 2010 and is headquartered in Ramboillet, France.

Robotiques 3 Dimensions SA specializes in the design and manufacture of collaborative robots. These systems are called cobots otherwise. These devices allow for industry sharing of roles on a workstation: the human and the specific smart move at cobot efforts and vibration. The company was founded by Serge Jean Grygorowicz in 2001 and is headquartered in Moneteau, France.

Krono-Safe SA provides software solutions for the development of embedded systems. It offers embedded operating systems for critical industrial applications such as automotive, aerospace, rail, energy and medical. The company was founded by Damien Chabrol and Didier Roux in 2011 and is headquartered in Orsay, France.

GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France.

Bioaxial SAS develops and supplies live cell imaging instruments. It develops, manufactures and markets a super-resolution instrument for the life sciences and medical research communities. The firm's products include add-on module CODIM100 and Stand-Alone. The company was founded by Louis-Philippe Braitbart and Gabriel Sirat on February 24, 2010 and is headquartered in Paris, France.

Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France.

Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France.

Prestodiag SAS develops, manufactures and markets a life science developments platform aimed at reducing the time and effort to detect microbiological pathogens. Its products include MonoPresto and Detection Kits. The company was founded by Thierry Livache, Thibaut Mercey and Felix Piat in March 2012 and is headquartered in Villejuif, France.

NAWATechnologies SA engages in developing and industrialising electrode material that combines nano and clean technologies. The firm’s products include NAWACAP, a new generation of ultra rapid carbon batteries based on the principle of supercapacitors; and NawaTECH, a technological platform for custom-made solutions. The company was founded by Pascal Boulanger and Ludovic Eveillard in April 2013 and is headquartered in Rousset Cedex, France.

CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France.

Apix Analytics SA develops miniaturized multigas analyzers systems based on integration on silicon of traditional analytical chains. Its products include analytical module, ChromPix, portable system and Max-One. The company was founded by Philippe Andreucci, Pierre Puget, Eric Colinet and Joshua Whiting on June 25, 2014 and is headquartered in Grenoble, France.

Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France.

Part of Pfizer Inc., Pfizer SAS (France) is a French company that manufactures biopharmaceuticals. The private company is based in Paris, France. The company was founded in 2000. Franck Le Breguero has been the CEO of the company since 2016.

UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France.

Diabeloop SAS develops an electronic artificial pancreas for patients suffering from diabetes 1 in order to reduce hypoglycemia. The company was founded on March 24, 2015 and is headquartered in Grenoble, France.

LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France.

Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation.

The European Synchrotron Radiation Facility provides the international science community with tools to study materials and living matter. The private company is based in Grenoble, France.